1.4K
Articles
61.2K
Citations
3.9
avg. Impact Factor
118
h-index

Most Cited Articles of Division of Cardiology in 2011

TitleJournalYearCitations
Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathyCirculation2011251
down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4Journal of Biological Chemistry2011205
Micromanaging vascular smooth muscle cell differentiation and phenotypic modulationArteriosclerosis, Thrombosis, and Vascular Biology2011164
Acquired long QT syndrome from stress cardiomyopathy is associated with ventricular arrhythmias and torsades de pointesHeart Rhythm2011141
Hypoxia potentiates microRNA-mediated gene silencing through posttranslational modification of Argonaute2Molecular and Cellular Biology2011107
Heart failure with preserved ejection fractionCirculation201191
Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)Journal of the American College of Cardiology201178
A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide and the combination of tolvaptan and furosemide in patients with heart failure and systolic dysfunctionJournal of Cardiac Failure201173
Aldosterone regulates vascular gene transcription via oxidative stress-dependent and -independent pathwaysArteriosclerosis, Thrombosis, and Vascular Biology201168
Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolyticsJournal of Thoracic and Cardiovascular Surgery201163
Bivalirudin is a dual inhibitor of thrombin and collagen-dependent platelet activation in patients undergoing percutaneous coronary interventionCirculation: Cardiovascular Interventions201151
Augmentation index derived from peripheral arterial tonometry correlates with cardiovascular risk factorsCardiology Research and Practice201150
Incidence and significance of pacemaker and implantable cardioverter-defibrillator lead masses discovered during transesophageal echocardiographyPACE - Pacing and Clinical Electrophysiology201148
Direct vasorelaxation by a novel phytoestrogen tanshinone IIA is mediated by nongenomic action of estrogen receptor through endothelial nitric oxide synthase activation and calcium mobilizationJournal of Cardiovascular Pharmacology201146
Associations of edge-detected and manual-traced common carotid intima-media thickness measurements with Framingham risk factors: the multi-ethnic study of atherosclerosisStroke201145
Pressure-volume relationships in patients with transthyretin (ATTR) cardiac amyloidosis secondary to V122I mutations and wild-type transthyretin: Transthyretin Cardiac Amyloid Study (TRACS)Circulation: Heart Failure201144
Novel inactivating mutations in the GH secretagogue receptor gene in patients with constitutional delay of growth and pubertyEuropean Journal of Endocrinology201142
MicroRNA expression data reveals a signature of kidney damage following ischemia reperfusion injuryPLoS ONE201141
Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathwaysJournal of Ethnopharmacology201139
Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fractionCirculation: Heart Failure201131
ANGPTL4 variants E40K and T266M are associated with lower fasting triglyceride levels in Non-Hispanic White Americans from the Look AHEAD Clinical TrialBMC Medical Genetics201130
Autopsy validation study of the academic research consortium stent thrombosis definitionJACC: Cardiovascular Interventions201130
Effects of tolvaptan on physician-assessed symptoms and signs in patients hospitalized with acute heart failure syndromes: analysis from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan (EVEREST) trialsAmerican Heart Journal201129
Transforming growth factor-β: governing the transition from inflammation to fibrosis in heart failure with preserved left ventricular functionCirculation: Heart Failure201128
Smad-mediated miRNA processing: a critical role for a conserved RNA sequenceRNA Biology201125